Cerebellum and Cortical Plasticity: the Case of Dystonia (CERDYS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Institut National de la Santé Et de la Recherche Médicale, France.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Policlinico G . Martino, Messina Italy
Information provided by (Responsible Party):
Institut National de la Santé Et de la Recherche Médicale, France
ClinicalTrials.gov Identifier:
NCT01272154
First received: January 5, 2011
Last updated: January 27, 2012
Last verified: January 2012
  Purpose

Purpose

- Objective : Sensorimotor adaptation allows the modification of the motor command taking into account the errors detected during execution of prior movements. It involves a large cortico-subcortical network. Isolated lesions of this network do not systematically alter sensorimotor adaptation except for cerebellar lesions. The cerebellum is thus a key structure for sensorimotor adaptation. However, the link between cerebellar and the cortical plasticity underlying sensorimotor adaptation remain unknown. Alteration of sensorimotor adaptation is associated with dystonia but it is unclear whether it is a cause or consequence of dystonia. It has been hypothesized that the abnormal plasticity observed in dystonia could account for the associated alteration of sensorimotor adaptation.

Classically, basal ganglia dysfunction is considered to be crucial for dystonia pathogenesis. However, recent studies suggest that the involvement of the cerebellum may also be important in this setting. In primary dystonia, imaging studies showed abnormal cerebellar activation during sensorimotor adaptation tasks and neurophysiological studies demonstrated a decrease of cerebellar output.

The aim of this study is to investigate the role of the cerebellum in the cortical plasticity underlying sensorimotor adaptation both in healthy subjects (normal plasticity) and in dystonic patients (abnormal plasticity).

- Methods: Paired associative stimulation PAS consists in repetitive pairing of a peripheral nerve and a cortical stimulation. This kind of stimulation has been designed to induce artificial plasticity that can be easily measured. This PAS induced sensorimotor plasticity is exacerbated and has lost its topographical specificity in dystonic patients.TMS using trains of TMS pulses (rTMS) can be applied on the cerebellum to modulate its output. We will test the effect of rTMS induced modulation (cTBS- inhibitory, iTBS-excitatory, sham) of the cerebellar output on PAS induced plasticity in patients with dystonia and healthy control.

We will also assess the acute effect of the rTMS induced modulation of the cerebellar output on the dystonic symptoms and on the performance at a validated sensorimotor adaptation task. This will be done by double blind post-hoc scoring of the dystonia (BFM or TWSTRS) on standardized videorecording and measurement of the performance at the task after each rTMS session (cTBS, iTBS, sham).

Finally, we will assess the variation of PAS effect on other parameters reflecting cortical excitability after each rTMS session (cTBS, iTBS, sham).


Condition Intervention
Dystonia
Other: Transcranial magnetic stimulation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Cerebellum and Cortical Plasticity: the Case of Dystonia

Resource links provided by NLM:


Further study details as provided by Institut National de la Santé Et de la Recherche Médicale, France:

Primary Outcome Measures:
  • Comparison of MEP0/MEP10 and MEP0/MEP30 values obtained after sham, cRTBS or iTBS of the cerebellum. [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    The effect of rTMS induced modulation of the cerebellar output on the PAS induced plasticity will be assessed by measurement of the size variation of a 1mV test motor evoked potential (which reflect cortical excitability) before (MEP0) and 10 and 30 minutes (MEP10 and MEP30) after PAS. The primary outcome measure will be the comparison of MEP0/MEP10 and MEP0/MEP30 values obtained after sham, cRTBS or iTBS of the cerebellum.


Secondary Outcome Measures:
  • Variation of the appropriate dystonic clinical score (depending on the type of dystonia) after each rTMS session (cTBS, iTBS, sham). [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    The effect of rTMS induced modulation of the cerebellar output on dystonic symptoms will be assessed by the variation of the appropriate dystonic clinical score (depending on the type of dystonia) after each rTMS session (cTBS, iTBS, sham).

  • Measurement of number of errors, mean time to reach the target after each rTMS session (cTBS, iTBS, sham). [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    The effect of rTMS induced modulation of the cerebellar output on the performance at the sensorimotor adaptation task will be assessed by measurement of number of errors, mean time to reach the target after each rTMS session (cTBS, iTBS, sham).

  • Measurement of the variation of the motor threshold, intracortical inhibition and intracortical facilitation after each rTMS session (cTBS, iTBS, sham). [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    The effect of rTMS induced modulation of the cerebellar output on other parameter reflecting cortical excitability will be assessed by measurement of the variation of the motor threshold, intracortical inhibition and intracortical facilitation after each rTMS session (cTBS, iTBS, sham).


Estimated Enrollment: 120
Study Start Date: January 2011
Estimated Study Completion Date: January 2014
Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Primary cervical dystonia Patients Other: Transcranial magnetic stimulation
Transcranial magnetic stimulation (PAS and rTMS)
Experimental: Primary upperlimb Dystonia Patients Other: Transcranial magnetic stimulation
Transcranial magnetic stimulation (PAS and rTMS)
Experimental: Secondary Cervical or Upperlimb Dystonia due to cerebral palsy Other: Transcranial magnetic stimulation
Transcranial magnetic stimulation (PAS and rTMS)
Healthy volunteers Other: Transcranial magnetic stimulation
Transcranial magnetic stimulation (PAS and rTMS)

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion criteria

All subjects

  • Age >18 years and < 70 years
  • Normal physical and neurological examination, except for dystonia (when present)
  • No treatment with botulinum toxin during the last three months
  • No treatment altering the cortical excitability
  • Agreement to use a medically acceptable method of contraception throughout the study for female of childbearing potential

Primary focal dystonia group

  • Patients with cervical and/or upper limb dystonia
  • No cause of secondary dystonia

Secondary dystonia group

• Cervical dystonia and/or upper limb dystonia History of perinatal anoxia

Exclusion criteria

  • MMS ≤ 24/30
  • Current neurological or psychiatric illness other than dystonia.
  • Individual who is on medication which is known to lower seizure threshold (see lists above), or who has a pacemaker, an implanted medical pump, a metal plate, a metal plate or metal object in the skull or eye (for example after brain surgery) will be excluded
  • Uncontrollable medical problems not related to dystonia such as; cardiopulmonary disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer, or renal disease
  • Previous history of seizure(s) or current active epilepsy
  • Pregnancy, breast feeding women and women who are of childbearing age and not practicing adequate birth control.
  • Patients legally protected
  • Patients who are not enrolled at social security
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01272154

Contacts
Contact: Emmanuel Roze, MD, PhD +331 42 16 15 48 emmanuel.roze@psl.aphp.fr

Locations
France
Hpôpital Pitié Sapétrière - U 975 Plate forme " Pole Exploration de l'homme : Gait, Equilibrium, Posture, and Movement " Recruiting
Paris, France, 75013
Contact: Emmanuel Roze, MD    +331 42 16 15 48    emmanuel.roze@psl.aphp.fr   
Principal Investigator: Emmanuel Roze, MD, PhD         
Sponsors and Collaborators
Institut National de la Santé Et de la Recherche Médicale, France
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Policlinico G . Martino, Messina Italy
Investigators
Study Director: Emmanuel Roze, MD, PhD Institut National de la Santé Et de la Recherche Médicale, France
Principal Investigator: Asha Kishore, MD Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST)
Principal Investigator: Margherita Russo, MD Policlinico G . Martino
  More Information

No publications provided

Responsible Party: Institut National de la Santé Et de la Recherche Médicale, France
ClinicalTrials.gov Identifier: NCT01272154     History of Changes
Other Study ID Numbers: C10-01, 2010-A00931-38
Study First Received: January 5, 2011
Last Updated: January 27, 2012
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Keywords provided by Institut National de la Santé Et de la Recherche Médicale, France:
Cerebellum
Cortical plasticity
Sensorimotor adaptation
Dystonia
Cerebral Palsy
Transcranial Magnetic Stimulation
and

Additional relevant MeSH terms:
Dystonia
Dystonic Disorders
Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Movement Disorders
Central Nervous System Diseases

ClinicalTrials.gov processed this record on August 19, 2014